A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient-Reference-Cited by-同舟云学术

A novel e8a2 BCR-ABL1 intronic fusion through insertion of a chromosome 22 BCR gene fragment into chromosome 9 in an atypical Philadelphia (Ph) chromosome chronic myeloid leukemia patient

Published:2016-04-27 Issue:12 Volume:57 Page:2930-2933
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Chen Lifeng,Wu Yaohui,You Yong,Xiao Min,Yao Ye,Li Weiming

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2016.1173211

Reference12 articles.

1. Philadelphia-negative (Ph-) chronic myeloid leukemia (CML): comparison with Ph+ CML and chronic myelomonocytic leukemia. The Groupe Francais de Cytogenetique Hematologique

2. Molecular characterization and follow-up of five CML patients with new BCR-ABL1 fusion transcripts

3. e8a2 BCR–ABL: more frequent than other atypical BCR–ABL variants?

4. Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Recurrent Atypical e8a2 <i>BCR::ABL1</i> Transcript with Insertion of an Inverted 55 Base Pair <i>ABL1</i> Intron 1b Sequence: A Detailed Molecular Analysis;Acta Haematologica;2023-05-19

2. Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors;International Journal of Hematology;2022-09-10

3. A Novel e8a2BCR-ABL1 Fusion Transcript without Insertion Sequence in a Patient with Chronic Myeloid Leukemia;Annals of Laboratory Medicine;2018-03-28

4. Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2BCR-ABL1transcript with a somatic mutation inTP53BP2andcadherin-10genes;Leukemia & Lymphoma;2017-05-30